ClinicalTrials.gg
Status unknownNCT05437627Updated Jun 29, 2022

Computerized Based Analysis for Detection and Severity Assessment of Stuttering

An observational study in Stuttering, sponsored by Assiut University. Status unknown. Open to participants aged 10 Years to 30 Years. Per ClinicalTrials.gov, last updated 2022-06-29.

Sponsored by Assiut University · Observational

The sponsor has not verified this record recently (last verified Jun 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
120
Ages
10 Years to 30 Years
Sex
All
01

Study summary

In the light of previous attempts to design and develop automated and objective measures for automatic speech recognition system that detects disfluent speech and assess its severity, yet fully automated measurement of stuttered speech is not available. This study was triggered by the need to design and develop a simple and reliable computerized tool for identification of stuttering and measurement for its severity. Therefore, the aim of this study is to develop a user interface that can work on windows system for the adopted stuttering recognition model which can be used in clinical practice by physicians and therapists.

Read the detailed description

Stuttering is a speech disorder in which the normal flow of speech is disrupted by occurrences of dysfluencies, such as repetition, prolongations and blocks (1). Features that have been found to differ between stutterers and nonstutterers are rate of speech and frequency of dysfluent utterances (2).

An Arabic version of stuttering severity instrument (A-SSI) is used to assess the stuttering severity In it, the overall severity score of stuttering is measured by combining the scores of percentages of Stuttered Syllables (%SS), Mean Duration of the Three Longest Stuttering Events (MDTLSE), and Physical Concomitants (PC) (3).

The subjective assessment methods of stuttering are; time-consuming, prone to error, subjective (4), so it is better to automate the measurement of disfluencies using speech recognition technologies and computational intelligence (5).

Speech recognition executes a task similar to what the human brain undertakes (6). Stuttering detection system has three main steps which are acoustic processing, feature extraction and classification/recognition (7). the speech signals are pre-processed (8), and certain features are extracted from them by signal processing techniques, e.g. Mell frequency cepstral coefficients (MFCC) (9). (MFCC) is considered the most popular used feature extraction technique (10).

The classification process contains two steps; training and testing (11). In training process, data is labeled based on the classes and a model is learned. In testing phase: the model is tested and computed the accuracy, sensitivity, and specificity of the classification models (11). Finally, stuttering from non-stuttering speech will be recognized and separated (5) also to assess the severity of stuttered speech.

02

Conditions studied

  • Stuttering

Browse trials for

03

In context

Stuttering

74 studies on the registry are indexed under Stuttering; 23 are open to participants now.

This study's planned enrollment of 120 is above the median of 60 across 15 observational studies indexed under Stuttering.

Browse Stuttering studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 30 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The study will be included one hundred twenty (120) subjects; age ranges (10-30 years). They will be recruited from the outpatient clinic of Phoniatric Unit, Assiut University Hospital. The study is supposed to be conducted in one up to 2 years. They will be divided into two groups:

  1. Study Group: This will be consisted of sixty (60) stuttering patients. They will be divided into 2 subgroups; children group 30 patients with age ranges from (10-18y) and adult group 30 patients with age ranges from (19-30y)
  2. Control Group: This will be consisted of sixty (60) subjects who have normal fluency. They will be selected from the relative of the patients attending to the outpatient clinic and will be matched for age, sex and socioeconomic state with the patients group.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age: from 10 to 30 years old.
  2. Gender: both sexes will be included in the study.
  3. The participants in the study group suffering from developmental stuttering (stuttering symptoms was of early childhood onset, intermittent course and dated since early childhood) seeking speech therapy
  4. Have language aptitudes coping with his or her chronological age.

Exclusion criteria

Exclusion Criteria:

    1. Presence of any other speech or language disorders. 2. Mental Retardation. 3. Poor scholastic performances. 4. Presence of any psychiatric or neurologic disorders.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
120 participants (estimated)
Target follow-up
3 Months
Patient registry
Yes

Groups and cohorts

  • Study Group:

    Study Group: This will be consisted of sixty (60) stuttering patients. They will be divided into 2 subgroups; children group 30 patients with age ranges from (10-18y) and adult group 30 patients with age ranges from (19-30y)

    Diagnostic Test: The Arabic version of Stuttering Severity Instrument-3 (ASSI3) for children and adults

  • Control Group

    Control Group: This will be consisted of sixty (60) subjects who have normal fluency. They will be selected from the relative of the patients attending to the outpatient clinic and will be matched for age, sex and socioeconomic state with the patients group.

Interventions

  • Diagnostic testThe Arabic version of Stuttering Severity Instrument-3 (ASSI3) for children and adults

    Assessment of stuttering severity: The Arabic version of Stuttering Severity Instrument-3 (ASSI3) for children and adults will be applied for assessment of severity of stuttering. (3). Automatic detection and severity assessment of stuttering using MATLAB version 8.1.0.604 R2013a (7). Stuttering detection system has three main steps which are acoustic processing, feature extraction and classification/recognition

    Also known as: A. Acoustic voice analysis, B. Spectral analysis:, Automatic detection and severity assessment of stuttering

06

What researchers measure

Primary outcomes

  1. Assessment of stuttering severity:

    using both subjective method as The Arabic version of Stuttering Severity Instrument-3 (ASSI3) for children and adults and objective method asAutomatic detection and severity assessment of stuttering

    Time frame: baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Bakker K, Brutten GJ. Speech-related reaction times of stutterers and nonstutterers: diagnostic implications. J Speech Hear Disord. 1990 May;55(2):295-9. doi: 10.1044/jshd.5502.295. PubMed 2329792 ↗
  • Andrews G, Craig A, Feyer AM, Hoddinott S, Howie P, Neilson M. Stuttering: a review of research findings and theories circa 1982. J Speech Hear Disord. 1983 Aug;48(3):226-46. doi: 10.1044/jshd.4803.226. PubMed 6353066 ↗
  • Yairi E. Subtyping stuttering I: a review. J Fluency Disord. 2007;32(3):165-96. doi: 10.1016/j.jfludis.2007.04.001. Epub 2007 Apr 24. PubMed 17825668 ↗
  • Prasse JE, Kikano GE. Stuttering: an overview. Am Fam Physician. 2008 May 1;77(9):1271-6. PubMed 18540491 ↗
  • SHERMAN D. Clinical and experimental use of the Iowa Scale of Severity of Stuttering. J Speech Hear Disord. 1952 Sep;17(3):316-20. doi: 10.1044/jshd.1703.316. No abstract available. PubMed 13053555 ↗
  • O'Brian S, Packman A, Onslow M, O'Brian N. Measurement of stuttering in adults: comparison of stuttering-rate and severity-scaling methods. J Speech Lang Hear Res. 2004 Oct;47(5):1081-7. doi: 10.1044/1092-4388(2004/080). PubMed 15603463 ↗
  • Enderby PM, John A. Therapy outcome measures in speech and language therapy: comparing performance between different providers. Int J Lang Commun Disord. 1999 Oct-Dec;34(4):417-29. doi: 10.1080/136828299247360. PubMed 10884909 ↗
  • Prins D, Ingham RJ. Evidence-based treatment and stuttering--historical perspective. J Speech Lang Hear Res. 2009 Feb;52(1):254-63. doi: 10.1044/1092-4388(2008/07-0111). Epub 2008 Aug 11. Erratum In: J Speech Lang Hear Res. 2009 Apr;52(2):570. PubMed 18695017 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2022; primary completion for Sep 2024, 24 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 26, 2022
First posted
Jun 29, 2022
StartEst.
Sep 1, 2022
Primary completionEst.
Sep 30, 2024
CompletionEst.
Oct 1, 2024
Last update
Jun 29, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 29, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05437627
Lead sponsor
Assiut University
Responsible party
Asmaa Fathy (principal investigator, Assiut University) — Principal investigator
First posted
Jun 29, 2022
Start date
Sep 1, 2022 (estimated)
Primary completion
Sep 30, 2024 (estimated)
Completion
Oct 1, 2024 (estimated)
Last update
Jun 29, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion